The U.S. market for pain management devices is estimated to reach a value of nearly $2.7 billion by 2022, according to a recent report by Decision Resources Group.
The growth will primarily be driven by an increased focus on pain management as a result of CMS' incentives for facilities with high patient satisfaction ratings as well as pain research initiatives from the Patient Protection and Affordable Care Act. Healthcare facilities will also place a greater emphasis on pain management to help reduce hospital stays, thereby reducing costs, according to the report.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws